Cardiac receptor physiology and its application to clinical imaging: Present and future

Journal of Nuclear Cardiology

Volumn 8, Issue 3, 2001, Pages 390-409

  Tseng, Hennessey ^a   Link, Jeanne M ^a   Stratton, John R ^a   Caldwell, James H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CELL SURFACE RECEPTOR; MUSCARINIC RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HEART DISEASE; HUMAN; HUMAN TISSUE; INFORMATION; NONHUMAN; PATHOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOACTIVITY; RECEPTOR BINDING; REGULATORY MECHANISM; SCINTISCANNING; THERAPY;

EID: 0034977054     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2001.115645     Document Type: Article

References (135)

1. Receptors
2. Adrenergic and muscarinic receptors of the heart
3. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters
4. Regulation of β-adrenoceptor signaling in cardiac function and disease
5. Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model
6. Differential regulation of mRNA specific for β1-β2-adrenergic receptors in human failing hearts: Evaluation of the absolute cardiac mRNA levels by two independent methods
7. Role of clathrin-mediated endocytosis in agonist-induced down-regulation of the beta-2 adrenergic receptor
8. Kinetic analysis of agonist-induced down-regulation of the beta(2)-adrenergic receptor in BEAS-2B cells reveals high- and low-affinity components
9. Increased beta-adrenergic receptor density in an experimental model of cardiac transplantation
10. Isolated hormone receptors physiologic and clinical implications
11. Polymerase chain reaction screening of genomic libraries for adrenergic receptor genes
12. Modulation of human cardiac function through 4 beta-adrenoceptor populations
13. The adenylyl cyclases as integrators of transmembrane signal transduction
14. Beta 1- and beta 2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure
15. Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart
16. β1- and β2-adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective β1-adrenoceptor down-regulation in heart failure
17. Comparison of rat and human left ventricle beta-adrenergic receptors: Subtype heterogeneity delineated by direct radioligand binding
18. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle
19. 2+ current: Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation
20. Structural basis for receptor subtype-specific regulation revealed by a chimeric β3-/β2-adrenergic receptor
21. Vagal control of the heart: Experimental basis and clinical implications
22. Muscarinic receptors-characterization, coupling and function
23. Differential effect of pertussis toxin on adenosine and muscarinic inhibition of cyclic AMP accumulation in canine ventricular myocytes
24. Muscarinic receptors in the failing human heart
25. Epinephrine kinetics in humans: Radiotracer methodology
26. Beta-adrenergic blockade decreases norepinephrine release in humans
27. Decreased basal cardiac interstitial norepinephrine release after neuronal uptake inhibition in dogs
28. Cardiac sympathetic nerve function in congestive heart failure
29. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy
30. Age-related changes in β-adrenergic neuroeffector systems in the human heart
31. Beta-adrenergic effects on left ventricular filling: Influence of aging and exercise training
32. Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men
33. Tracer kinetic modeling in nuclear cardiology
34. Myocardial imaging in man with I-123 meta-iodobenzylguanidine
35. Myocardial imaging with a radioiodinated norepinephrine storage analog
36. Iodine-131 meta-iodobenzylguanidine intra- and extravesicular accumulation in the rat heart
37. Scintigraphic assessment of regional cardiac adrenergic innervation
38. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy
39. Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy
40. In vivo assessment of neurotransmitter system in cardiovascular diseases: Clinical issues
41. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy
42. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: Value of cardiac and pulmonary iodine-123 MIBG uptake
43. 123I-MIBG scintigraphic study
44. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy
45. Use of iodine-123 meta-iodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus
46. Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: One-year follow-up with improved metabolic control
47. Radiolabeled ligands for imaging the muscarinic-cholinergic receptors of the heart and brain
48. Evaluation of Z-(R, R)-IQNP for the potential imaging of m2 mAChR rich regions of the brain and heart
49. 11C]m-hydroxyephedrine in the rat
50. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: A false transmitter agent for heart neuronal imaging
51. 11C]-meta-hydroxyephedrine and metabolites in plasma
52. 11)C]hydroxyephedrine and positron emission tomography
53. Myocardial kinetics of carbon-11-meta-hydroxyephedrine: Retention mechanisms and effects of norepinephrine
54. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans
55. Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography
56. Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart
57. Quantitation of presynaptic cardiac sympathetic function with carbon-11-meta-hydroxyephedrine
58. 3H] CGP- 12177 to cardiac tissue slices: Characterization and ontogenetic studies in dogs
59. 3H CGP12177) receptor binding in hamster and guinea pig heart
60. 3H-CGP 12177 to β-adrenoceptors in rat myocardial membranes
61. Uptake of radioligands by rat heart and lung in vivo: CGP 12177 does and CGP 26505 does not reflect binding to beta-adrenoceptors
62. 11C]CGP-12177 and PET
63. 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy
64. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method
65. Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data
66. Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart
67. Positron emission tomography: Evaluation of cardiac receptors
68. 11C] CGP12388) and
69. 11C] CGP 20712A) 1-adrenoceptor ligand for PET
70. 11C]formoterol and positron emission tomography
71. 18F]fluorocarazolol in intact rats reflects radioligand binding to beta-adrenoceptors
72. Synthesis and in vitro and in vivo characteristics of an iodinated analogue of the beta-adrenoceptor antagonist carazolol
73. 18F]fluorocarazolol, ligands for the visualization of pulmonary beta-adrenergic receptors with PET
74. Specific beta-adrenergic receptor binding of carazolol measured with PET
75. Cardiovascular alpha 1-adrenoceptor subtypes: Functions and signaling
76. Role of alpha 1-adrenoceptor subtypes in production of the positive inotropic effects in mammalian myocardium: Implications for the alpha 1-adrenoceptor subtype distribution
77. Function of myocardial alpha-adrenoceptors
78. Cardiac alpha(1)-adrenoceptors that regulate contractile function: Subtypes and subcellular signal transduction mechanisms
79. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice
80. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission
81. 11C]GB67, a novel radioligand for imaging myocardial alpha 1-adrenoceptors with positron emission tomography
82. 11C]MK-912 as an alpha2-andrenergic receptor radioligand for PET studies
83. Muscarinic cholinergic receptor in the human heart evidenced under physiological conditions by positron emission tomography
84. Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy: An in vivo PET study
85. Direct effects of angiotensin I, angiotensin II, an ACE inhibitor and a serine proteinase inhibitor on cultured heart cells from spontaneously hypertensive rats
86. Molecular cloning of AT1 angiotensin receptors
87. Myocardial angiotensin receptors in human hearts
88. Cardiac effects of AII-AT1A receptor signaling, desensitization, and internalization
89. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts
90. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction
91. 11C]L-159,884: A radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II, AT1 receptor imaging
92. In vivo labeling of angiotensin II receptors with a carbon-11-labeled selective nonpeptide antagonist
93. Investigation of angiotensin II/AT1 receptors with carbon-11-L-159,884: A selective AT1 antagonist
94. Nomenclature and classification of purinoceptors
95. Adenosine A2A receptors mediate coronary microvascular dilation to adenosine: Role of nitric oxide and ATP-sensitive potassium channels
96. A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: A role for nitric oxide
97. ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog
98. Characterization of a stimulatory adenosine A2a receptor in adult rat ventricular myocyte
99. A2A-adenosine receptor reserve for coronary vasodilation
100. 11C]KF17837
101. Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: A study with positron emission tomography
102. Myocardial beta adrenoceptor density in primary and secondary left ventricular hypertrophy
103. Pulmonary and cardiac beta-adrenoceptor density in vivo in asthmatic subjects
104. Distribution of beta-adrenergic receptors in failing human myocardium
105. Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: An analysis using carbon-11 hydroxyephedrine and positron emission tomography
106. 11C]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure
107. Regional pre- and postsynaptic sympathetic system in human heart-regulation of beta ARK-1
108. Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X
109. Regulation of beta-adrenergic receptors in acute myocardial ischemia: Subtype-selective increase of mRNA specific for beta 1-adrenergic receptors
110. Activation of beta-adrenergic receptor kinase during myocardial ischemia
111. Mechanisms of supersensitivity to sympathomimetic amines in chronically denervated heart of the conscious dog
112. Isolated presynaptic inotropic beta adrenergic supersensitivity of the transplanted denervated human heart in vivo
113. Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 hydroxyephedrine
114. Incomplete sympathetic reinnervation of the orthotopically transplanted human heart: Observation up to 13 years after heart transplantation
115. Sympathetic reinnervation of sinus node and left ventricle after heart transplantation in humans: Regional differences assessed by heart rate variability and positron emission tomography
116. Assessment of myocardial reinnervation in cardiac transplants by positron emission tomography: Functional significance tested by heart rate variability
117. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias
118. Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart
119. Scintigraphic pattern of regional cardiac sympathetic innervation in patients with familial long QT syndrome using positron emission tomography
120. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: Quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density emission tomography
121. Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia
122. Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia
123. Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine
124. Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography
125. Cardiac sympathetic dysinnervation in diabetes: Implications for enhanced cardiovascular risk
126. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: An assessment by C-11 hydroxyephedrine and positron emission tomography
127. Sympathetic cardioneuropathy in dysautonomias
128. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor
129. A gain-of-function polymorphism in a G-protein coupling domain of the human beta 1-adrenergic receptor
130. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties
131. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells
132. Imaging gene expression: Principles and assays
133. Differential expression of angiotensin receptor 1A and 1B in mouse
134. Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study